Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB)

ISSN： 1464-5246

Source： Journal of Microencapsulation, Vol.30, Iss.1, 2013-02, pp. : 49-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood––brain barrier

By Tosi Giovanni Fano Rita Adriana Bondioli Lucia Badiali Luca Benassi Rois Rivasi Francesco Ruozi Barbara Forni Flavio Vandelli Maria Angela

Nanomedicine, Vol. 6, Iss. 3, 2011-04 ,pp. : 423-436

Future Medicine

Access to resources Recommend Favorite

Why Clinical Modulation of Efflux Transport at the Human Blood–Brain Barrier Is Unlikely: The ITC Evidence‐Based Position

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 1, 2013-07 ,pp. : 80-94

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patented In Vitro Blood-Brain Barrier Models in CNS Drug Discovery

Recent Patents on CNS Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 107-118

Bentham Science Publishers

Access to resources Recommend Favorite

Blood–brain barrier: An impediment to neuropharmaceuticals

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 4, 2015-04 ,pp. : 308-313

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improving drug delivery to primary and metastatic brain tumors: Strategies to overcome the blood–brain barrier

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 4, 2015-04 ,pp. : 336-346

John Wiley & Sons Inc

Access to resources Recommend Favorite